Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development (Q45370951)

13 December 2017

title

Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: implication in vaccine development (English)

1 reference

Venezuelan equine encephalitis

13 December 2017

1 reference

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis virus

object named as

Venezuelan equine encephalitis virus

1 reference

Anuj Sharma

1

1 reference

13 December 2017

Paridhi Gupta

2

1 reference

13 December 2017

Pamela J Glass

3

1 reference

13 December 2017

Michael D Parker

4

1 reference

13 December 2017

Radha K Maheshwari

5

1 reference

13 December 2017

language of work or name

English

0 references

publication date

27 November 2010

1 reference

13 December 2017

1 reference

13 December 2017

volume

29

1 reference

13 December 2017

issue

5

1 reference

13 December 2017

page(s)

953-959

1 reference

Venezuelan equine encephalitis

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Gene expression profiling of nonhuman primates exposed to aerosolized Venezuelan equine encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Biological weapons--a primer for microbiologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Venezuelan equine encephalitis virus transmission and effect on pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

REVIEW PAPER: pathology of animal models of alphavirus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

TC-83 Venezuelan equine encephalitis vaccine exposure during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Complete inactivation of Venezuelan equine encephalitis virus by 1,5-iodonaphthylazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Red cell membrane glycophorin labeling from within the lipid bilayer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Selective labeling of proteins in biological systems by photosensitization of 5-iodonaphthalene-1-azide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

5-[125I]Iodonaphthyl azide, a reagent to determine the penetration of proteins into the lipid bilayer of biological membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Selective photoinduced uncoupling of the response of adenylate cyclase to gonadotropins by 5-iodo-1-naphthylazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Protection of hamsters by Venezuelan equine encephalitis virus candidate vaccine V3526 against lethal challenge by mosquito bite and intraperitoneal injection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Sindbis virus: propagation, quantification, and storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.033

10.1016/J.VACCINE.2010.11.033

7 January 2021

Identifiers

DOI

1 reference

13 December 2017

1 reference